Assessment of the scientific information for the radiation exposure screening and education program
著者
書誌事項
Assessment of the scientific information for the radiation exposure screening and education program
National Academies Press, c2005
大学図書館所蔵 全1件
  青森
  岩手
  宮城
  秋田
  山形
  福島
  茨城
  栃木
  群馬
  埼玉
  千葉
  東京
  神奈川
  新潟
  富山
  石川
  福井
  山梨
  長野
  岐阜
  静岡
  愛知
  三重
  滋賀
  京都
  大阪
  兵庫
  奈良
  和歌山
  鳥取
  島根
  岡山
  広島
  山口
  徳島
  香川
  愛媛
  高知
  福岡
  佐賀
  長崎
  熊本
  大分
  宮崎
  鹿児島
  沖縄
  韓国
  中国
  タイ
  イギリス
  ドイツ
  スイス
  フランス
  ベルギー
  オランダ
  スウェーデン
  ノルウェー
  アメリカ
注記
Includes bibliographical references (p. 309-329)
"Supported by the National Academy of Sciences and the Health Resources and Services Administration DHHS 232-02-0004"
内容説明・目次
内容説明
The Radiation Exposure Compensation Act (RECA) was set up by Congress in 1990 to compensate people who have been diagnosed with specified cancers and chronic diseases that could have resulted from exposure to nuclear-weapons tests at various U.S. test sites. Eligible claimants include civilian onsite participants, downwinders who lived in areas currently designated by RECA, and uranium workers and ore transporters who meet specified residence or exposure criteria. The Health Resources and Services Administration (HRSA), which oversees the screening, education, and referral services program for RECA populations, asked the National Academies to review its program and assess whether new scientific information could be used to improve its program and determine if additional populations or geographic areas should be covered under RECA. The report recommends Congress should establish a new science-based process using a method called "probability of causation/assigned share" (PC/AS) to determine eligibility for compensation. Because fallout may have been higher for people outside RECA-designated areas, the new PC/AS process should apply to all residents of the continental US, Alaska, Hawaii, and overseas US territories who have been diagnosed with specific RECA-compensable diseases and who may have been exposed, even in utero, to radiation from U.S. nuclear-weapons testing fallout. However, because the risks of radiation-induced disease are generally low at the exposure levels of concern in RECA populations, in most cases it is unlikely that exposure to radioactive fallout was a substantial contributing cause of cancer.
Table of Contents
Front Matter
Executive Summary
1 Introduction
2 Legislation and Compensation
3 Basic Concepts in Radiation Physics, Biology, and Epidemiology
4 Review of Recent Data on Radiation Epidemiology, Biology, and
Dosimetry
5 Expanding RECA Eligibility: Scientific Issues
6 Expanding RECA Eligibility: Implementation
7 Diseases, Populations, and Other Issues of Public Concern
8 Ethical Framework
9 Medical Screening
10 Screening for Compensation
11 Education and Outreach
References
Appendix A: Invited Speakers and Public Comment
Appendix B: A Comparison of the Risk of Skin Cancer with the Risk
of Lung Cancer from Exposure to Radon Decay Products in Underground
Mines
Appendix C: Radioactivity in Guam After Nuclear-Weapons Testing in
the Pacific
Appendix D: The Optimal Criterion for Positivity in Screening
Appendix E: Selected Cancer-Screening Recommendations
Glossary
List of Abbreviations
Committee and Staff Biographies
目次
- 1 Front Matter
- 2 Executive Summary
- 3 1 Introduction
- 4 2 Legislation and Compensation
- 5 3 Basic Concepts in Radiation Physics, Biology, and Epidemiology
- 6 4 Review of Recent Data on Radiation Epidemiology, Biology, and Dosimetry
- 7 5 Expanding RECA Eligibility: Scientific Issues
- 8 6 Expanding RECA Eligibility: Implementation
- 9 7 Diseases, Populations, and Other Issues of Public Concern
- 10 8 Ethical Framework
- 11 9 Medical Screening
- 12 10 Screening for Compensation
- 13 11 Education and Outreach
- 14 References
- 15 Appendix A: Invited Speakers and Public Comment
- 16 Appendix B: A Comparison of the Risk of Skin Cancer with the Risk of Lung Cancer from Exposure to Radon Decay Products in Underground Mines
- 17 Appendix C: Radioactivity in Guam After Nuclear-Weapons Testing in the Pacific
- 18 Appendix D: The Optimal Criterion for Positivity in Screening
- 19 Appendix E: Selected Cancer-Screening Recommendations
- 20 Glossary
- 21 List of Abbreviations
- 22 Committee and Staff Biographies
「Nielsen BookData」 より